Drug Trial Radar · NCT05502237
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Jan 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,021
Actual
Start
Oct 12, 2022
Primary completion
Jun 2028
Study completion Jan 2029
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- Collaborators
- Arcus Biosciences, Inc.
- First posted
- Aug 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.
Conditions
- Non-small Cell Lung Cancer
Interventions
ZimberelimabDrug
Administered intravenously
DomvanalimabDrug
Administered intravenously
PembrolizumabDrug
Administered intravenously
CarboplatinDrug
Administered intravenously
CisplatinDrug
Administered intravenously
PaclitaxelDrug
Administered intravenously
Nab-paclitaxelDrug
Administered intravenously
PemetrexedDrug
Administered intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS) in Participants With Positive Programmed Cell Death-Ligand 1 (PD-L1) Expression (≥1%Tumor Cells) and in all Randomized Participants.Time frame: Up to 68 months
Locations
186 sites in 23 countries. Site status is shown where the registry gives one.
Innovative Clinical Research Institute
Whittier, California
George Washington Medical Faculty Associates
Washington D.C., District of Columbia
Moffitt Cancer Center
Tampa, Florida
Illinois Cancer Care
Peoria, Illinois
Messino Cancer Centers
Asheville, North Carolina
Oncology Hematology Care, Inc.
Cincinnati, Ohio
Hematology & Oncology Associates
Eugene, Oregon
AHN Allegheny General Hospital
Pittsburgh, Pennsylvania
Texas Oncology - Austin
Austin, Texas
Oncology and Hematology Associates of Southwest Virginia, Inc
Blacksburg, Virginia
Northwest Cancer Specialists, PC
Vancouver, Washington
Investigaciones CORI S.R.L.
Capital, Argentina
Centro Médico Privado Centro de Especialidades Médicas Ambulatorias e Investigación Clínica
Cardoba, Argentina
Sanatorio Allende
Córdoba, Argentina
Sanatorio Britanico de Rosario
Rosario, Argentina
Sanatorio Parque de Rosario
Rosario, Argentina
Hospital Provincial del Centenario
Rosario, Argentina
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Argentina
Clínica Viedma
Viedma, Argentina
Ordensklinikum Linz GmbH, Elisabethinen
Linz, Austria
Krankenhaus Nord - Klinik Floridsdorf
Vienna, Austria
Klinikum Wels-Grieskirchen
Wels, Austria
Algemeen Ziekenhuis Sint-Lucas
Aalst, Belgium
Grand Hopital de Charleroi asbl (GHdC)
Charleroi, Belgium
AZ Sint-Maarten
Mechelen, Belgium
CHU UCL Namur / Site Sainte Elisabeth
Namur, Belgium
Cenantron Centro Avançado de Tratamento Oncologico Ltda
Belo Horizonte, Brazil
Hospital Evangelico de Cachoeiro de Itapemirim
Cachoeiro de Itapemirim, Brazil
Fundacao Universidade De Caxias Do Sul - FUCS/RS
Caxias do Sul, Brazil
Instituto do Câncer do Ceará - ICC
Fortaleza, Brazil
Oncosite - Centro de Pesquisa Clinica em Oncologia LTDA
Ijuí, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
Hospital São Lucas da PUCRS
Porto Alegre, Brazil
Hospital Ana Nery Santa Cruz do Sul
Santa Cruz do Sul, Brazil
Instituto Brasiliero de Controle do Cancer IBCC
São Paulo, Brazil
Centro Des Pesquisas Clinicas da Fundacao Doutor Amaral Carvalho
São Paulo, Brazil
Centre Integre de sante et de services sociaux de la Monteregie Centre
Greenfield Park, Canada
Moncton Hospital
Moncton, Canada
CISSS des Laurentides
Québec, Canada
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.